Post-approval studies (Phase 4)Study completedNCT05002933
What this trial is testing
A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period
Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 570